Compara mètodes

	Escala d'Adherència Hill-Bone (HBCS)	Questionari de Satisfacció amb el Tractament Farmacològic (TSQM)
Camp	Farmacologia	Farmacologia
Família	Process / pipeline	Process / pipeline
Any d'origen	1999	2004
Autor original	Marjorie T. Kim, Mozella N. Hill, Lisa R. Bone, and Debra M. Levine	Mary Jo Atkinson and colleagues
Tipus	Self-report	Self-report
Font seminal	Kim, M. T., Hill, M. N., Bone, L. R., & Levine, D. M. (1999). Development and Testing of the Hill-Bone Compliance Scale. Journal of Cardiovascular Nursing, 4(1), 54-59. (Also: Hill, M. N., Bone, L. R., & Kim, M. T. (1996). Perspective on compliance research in hypertension. Journal of Clinical Hypertension, 8(1), 12-17.)	Atkinson, M. J., Sinha, A., Hass, S. L., Colman, S. S., Kumar, R. N., Berman, B. M., & Wolpert, B. (2004). Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel of chronically ill individuals. Health and Quality of Life Outcomes, 2(1), 12.
Àlies	HBCS	TSQM
Relacionats	4	4
Resum	The Hill-Bone Compliance Scale (HBCS) is a brief, disease-specific self-report measure designed to assess medication and lifestyle adherence in hypertension management. Developed by Kim, Hill, Bone, and Levine at Johns Hopkins University in 1999, the HBCS measures three dimensions of hypertension adherence: medication-taking, dietary sodium restriction, and appointment keeping. Unlike generic adherence measures, the HBCS captures the multifaceted nature of hypertension self-management, recognizing that many hypertensive patients struggle equally with medication adherence and behavioral changes (diet, exercise, weight management, stress management). The scale has demonstrated strong reliability and validity in diverse hypertensive populations and remains widely used in hypertension research and clinical management.	The Treatment Satisfaction Questionnaire for Medication (TSQM) is a 14-item generic measure developed by Atkinson and colleagues in 2004 to assess patient satisfaction with medication across diverse therapeutic areas and disease conditions. It measures four key dimensions—Effectiveness, Side Effects, Convenience, and Global Satisfaction—with standardized 0–100 scoring, making it suitable for cross-disease comparison and health economic evaluation. The TSQM has become a standard outcome in pharmaceutical research, clinical trials, and real-world medication effectiveness studies.